← AbbVie Inc. ABBV
Market Price
$249.34
Market Cap
$443.15B
P/E Ratio
105.65
Revenue (FY 2025)
↑8.6% YoY
$61.16B
3-Yr CAGR: 1.8%
Net Income
↓-1.2% YoY
$4.23B
Net Margin: 6.9%
Free Cash Flow
↓-0.1% YoY
$17.82B
FCF Yield: 4.02%
EPS (Diluted)
↓-1.3% YoY
$2.36
Basic: $2.37
Return on Equity
Efficiency
N/A
ROA: 14.5%
⚡ N/A due to negative equity (share buybacks or other)
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ABBV)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $25,638.0M | — | $19,805.0M | $5,953.0M | — | $3.63 | — | $7,041.0M | $6,562.0M | — |
| FY 2017 | $28,216.0M | +10.1% | $21,176.0M | $5,309.0M | -10.8% | $3.30 | -9.1% | $9,960.0M | $9,431.0M | +43.7% |
| FY 2018 | $32,753.0M | +16.1% | $25,035.0M | $5,687.0M | +7.1% | $3.66 | +10.9% | $13,427.0M | $12,789.0M | +35.6% |
| FY 2019 | $33,266.0M | +1.6% | $25,827.0M | $7,882.0M | +38.6% | $5.28 | +44.3% | $13,324.0M | $12,772.0M | -0.1% |
| FY 2020 | $45,804.0M | +37.7% | $30,417.0M | $4,616.0M | -41.4% | $2.72 | -48.5% | $17,588.0M | $16,790.0M | +31.5% |
| FY 2021 | $56,197.0M | +22.7% | $38,751.0M | $11,542.0M | +150.0% | $6.45 | +137.1% | $22,777.0M | $21,990.0M | +31.0% |
| FY 2022 | $58,054.0M | +3.3% | $40,640.0M | $11,836.0M | +2.5% | $6.63 | +2.8% | $24,943.0M | $24,248.0M | +10.3% |
| FY 2023 | $54,318.0M | -6.4% | $33,903.0M | $4,863.0M | -58.9% | $2.72 | -59.0% | $22,839.0M | $22,062.0M | -9.0% |
| FY 2024 | $56,334.0M | +3.7% | $39,430.0M | $4,278.0M | -12.0% | $2.39 | -12.1% | $18,806.0M | $17,832.0M | -19.2% |
| FY 2025 | $61,160.0M | +8.6% | $42,956.0M | $4,226.0M | -1.2% | $2.36 | -1.3% | $19,030.0M | $17,816.0M | -0.1% |
Valuation
Market Price
$249.34
Market Cap
$443.15B
Enterprise Value
$502.42B
P/E Ratio
105.65
P/B Ratio
N/A
FCF Yield
4.02%
Dividend Yield
2.67%
Shares Outstanding
Profitability & Margins
Gross Margin
70.24%
Operating Margin
24.65%
Net Margin
6.91%
Return on Equity (ROE)
N/A (Negative Equity)
Return on Assets (ROA)
14.54%
Asset Turnover
2.10x
Revenue 3-Yr CAGR
1.75%
Financial Health & Liquidity
Current Ratio
0.67
Cash Ratio
0.12
Debt / Equity
-19.726
Debt / Assets
2.219
Cash & Equivalents
$5.23B
Total Debt
$64.50B
Book Value / Share
$-1.85
Cash Flow Efficiency
Operating Cash Flow
$19.03B
Capital Expenditures (CapEx)
$1.21B
Free Cash Flow
$17.82B
OCF / Revenue
31.12%
FCF / Revenue
29.13%
FCF 3-Yr CAGR
-9.76%
Per Share Metrics
EPS (Diluted)
$2.36
EPS (Basic)
$2.37
Dividends / Share
$6.65
Book Value / Share
$-1.85
EPS YoY Growth
-1.26%
Balance Sheet (FY 2025)
Total Assets
$29.06B
Total Liabilities
$43.29B
Stockholders' Equity
-$3.27B
Current Assets
$29.06B
Current Liabilities
$43.29B